Apollo Endosurgery, Inc.
APEN · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $57 | $91 | $36 | $30 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $15 | $10 | $8 | $9 |
| Inventory | $18 | $12 | $10 | $9 |
| Other Curr. Assets | $3 | $2 | $4 | $3 |
| Total Curr. Assets | $93 | $115 | $59 | $51 |
| Property Plant & Equip (Net) | $8 | $6 | $6 | $7 |
| Goodwill | $5 | $5 | $5 | $5 |
| Intangibles | $3 | $4 | $6 | $8 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $2 | $1 | $4 |
| Total NC Assets | $17 | $17 | $19 | $24 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $110 | $132 | $77 | $75 |
| Liabilities | – | – | – | – |
| Payables | $7 | $5 | $4 | $10 |
| Short-Term Debt | $20 | $1 | $1 | $35 |
| Tax Payable | $1 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $11 | $9 | $7 | $7 |
| Total Curr. Liab. | $40 | $14 | $12 | $53 |
| LT Debt | $37 | $53 | $57 | $19 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $3 | $2 | $1 |
| Total NC Liab. | $38 | $56 | $59 | $20 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $78 | $70 | $71 | $72 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$337 | -$297 | -$273 | -$250 |
| AOCI | $5 | $2 | $3 | $2 |
| Other Equity | $365 | $357 | $277 | $251 |
| Total Equity | $33 | $61 | $7 | $2 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $110 | $132 | $77 | $75 |
| Net Debt | $0 | -$37 | $22 | $24 |